Clinical News

FDA okays biosimilar for several cancersWhile FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
FDA warns Pfizer’s Meridian over EpiPen flawsFDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
FDA warns about deaths in cancer drug trialsAn increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.
Will new biosimilars hurt blockbuster autoimmune drug?New biosimilars may harm the sales of this autoimmune blockbuster.
FDA okays targeted leukemia treatmentFDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
FDA eyes opioids in kids' medicinesAn FDA committee will review prescription opioid products containing hydrocodone or codeine to treat coughs in children.
Groups praise lawsuit against Walgreens, CVSPharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
FDA warns about contaminated drugs, dietary supplementsFDA warned consumers and health care professionals not to use a certain brand of drugs and dietary supplements that are contaminated.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA approves novel leukemia, hepatitis C drugsFDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.